Countable Labs, the developer of Countable PCR, a breakthrough single-molecule PCR technology redefining how science measures ...
Countable Labs has raised $26m to advance the development and commercialisation activities for its single-molecule polymerase chain reaction (PCR) technology. The California-based company's financing ...
PALO ALTO, Calif.--(BUSINESS WIRE)--Countable Labs (formerly Enumerix) enters the genomics market with the launch of Countable PCR, redefining what’s possible with PCR for rare event detection. By ...
Leading life sciences investors ARCH Venture Partners, F-Prime Capital, and Primer Ventures fuel company's expansion into cell and gene therapy, oncology, and molecular diagnostics PALO ALTO, Calif.-- ...
Countable Labs Brings Innovative, Single-Molecule, Counting-Based PCR to European Markets with CE Mark Clearance Countable PCR delivers single-molecule precision for Europe's most demanding ...
Conference Posters and Presentations at ASGCT Showcase Utility of Countable PCR in Single Molecule Quantification for Cell and Gene Therapy Applications Proof-of-Concept Assay Services Now Available; ...
Countable Labs has launched Countable 10, a PCR instrument capable of detecting 10 distinct fluorophores within a single reaction. The system extends the company’s Countable PCR technology, which ...
Countable Labs, announced the closing of an oversubscribed $26 million financing round to enable the development of fit-for-purpose solutions leveraging 10-color capabilities to support cell and gene ...
Alex Zevin, PhD, began serving as the director of the Genomics Shared Resource at Fred Hutch in December 2022. Before that, he was a research scientist at ArcherDX where he developed NGS in vitro ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results